Cart (0 Items)
Your cart is currently empty.
View Products
Ever since the discovery of hybridoma technology and its inherent limitations, monoclonal antibody production has gradually shifted from in vivo methods towards recombinant in vitro systems. Today, stable CHO cell…
Bispecific antibodies (bsAbs) have emerged as a powerful class of engineered therapeutics, particularly in oncology, due to their… Read More
Cancer treatment has progressively shifted from non-specific chemotherapy toward targeted and immune-based therapies. Among these innovations, monoclonal antibodies… Read More
Considered by many researchers as intermediate molecules, chimeric antibody constructs have been gradually losing ground to more effective molecules such… Read More
What Is Phage Display Technology & How Does It Shape Monoclonal Antibody Development? Scientists conducting research in industries from health… Read More
What are the structure and types of antibodies at the forefront of the immune response? Antibodies are one of the… Read More
What is cell line development, and what are the best methods and innovations for producing stable, high-yield cell lines in… Read More
Antibodies—whether polyclonal or monoclonal—are widely used in the scientific community for their specificity and sensitivity. In therapeutics, antibodies offer a… Read More
No matter what kind of project you’re working on—whether it's developing a therapeutic antibody or designing an immunoassay—your starting point… Read More
Choosing an expression system is a crucial decision for any laboratory, as it can have significant impacts on various projects. Read More